Anaptysbio Inc (ANAB) financials
Anaptysbio revenue and earnings by year
Anaptysbio's revenue was $235 million in the fiscal year to December 31, 2025, up 157.0% from the year before. Net income was -$13.2 million, -5.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 34.1% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 235 | 91 | 17 | 10 | 63 | 75 | 8 | 5 | 10 | 17 |
| Revenue growth | 157.0% | 432.0% | 66.8% | -83.7% | -15.8% | 837.5% | 60.0% | -50.0% | -40.1% | — |
| Operating income | 227 | 66 | -164 | -115 | -57 | -24 | -107 | -67 | -29 | -3 |
| Operating margin | 96.7% | 72.5% | -958.3% | -1119.4% | -89.9% | -31.8% | -1342.9% | -1334.4% | -287.8% | -18.1% |
| Net income | -13 | -145 | -164 | -129 | -58 | -20 | -97 | -62 | -30 | -4 |
| Net margin | -5.6% | -159.1% | -953.7% | -1251.3% | -91.5% | -26.6% | -1216.7% | -1233.1% | -300.7% | -25.5% |
| Diluted EPS | -$0.31 | -$3.41 | -$4.05 | -$3.05 | -$1.41 | — | -$2.41 | -$1.67 | -$1.09 | -$1.63 |
| Free cash flow | 20 | -135 | -122 | -74 | -47 | -15 | -70 | -50 | -20 | -9 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ANAB in Markets.
See also: ANAB returns
No forecast, no recommendation. This page describes Anaptysbio Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.